Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.45 |
| ▸ | CA1 | P00915 | 3/20 | 0.45 |
| ▸ | CA2 | P00918 | 3/20 | 0.45 |
| ▸ | CA4 | P22748 | 3/20 | 0.45 |
| ▸ | CA5A | P35218 | 3/20 | 0.45 |
| ▸ | CA7 | P43166 | 3/20 | 0.45 |
| ▸ | CA9 | Q16790 | 3/20 | 0.45 |
| ▸ | CA13 | Q8N1Q1 | 2/20 | 0.45 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.45 |
| ▸ | CA3 | P07451 | 1/20 | 0.45 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.45 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.45 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.45 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.45 |
| ▸ | SELP | P16109 | 1/20 | 0.44 |
| ▸ | PYGB | P11216 | 6/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20161428 | 0.98 | LGALS1 (0.48) | CA12CA1CA2CA4CA5A | |
| SCHEMBL28909019 | 0.98 | LGALS1 (0.48) | CA12CA1CA2CA4CA5A | |
| SCHEMBL7199426 | 0.98 | LGALS1 (0.48) | CA12CA1CA2CA4CA5A | |
| SCHEMBL20161429 | 0.98 | LGALS1 (0.48) | CA12CA1CA2CA4CA5A | |
| SCHEMBL18819645 | 0.88 | SELP (0.42) | CA12CA1CA2CA4CA5A | |
| SCHEMBL20888687 | 0.88 | SELP (0.42) | CA12CA1CA2CA4CA5A | |
| SCHEMBL18820215 | 0.86 | SELP (0.40) | CA12CA1CA2CA4CA5A | |
| SCHEMBL18820220 | 0.86 | PYGB (0.41) | CA12CA1CA2CA4CA5A | |
| SCHEMBL11698166 | 0.85 | — | — | |
| SCHEMBL3291698 | 0.82 | SELP (0.47) | CA12CA1CA2CA4CA5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2003062257-A1 | DEAZAPURINE NUCLEOSIDE ANALOGS AND THEIR USE AS THERAPEUTIC AGENTS | RIBAPHARM INC. (US) | 2003-07-31 | — | — | WO | disclosed |
| WO-2003052053-A2 | NUCLEOSIDE LIBRARIES AND COMPOUNDS BY MCC COMBINATORIAL STRATEGIES ON SOLID SUPPORT | RIBAPHARM INC. (US) | 2003-06-26 | — | — | WO | disclosed |